AlternativeStemetil / Buccastem
Prochlorperazine
Phenothiazine D2 antagonist antiemetic
Second-line NVP/HG antiemetic — buccal and IM formulations.
OralBuccalIM
First-line for
- Refractory nausea/vomiting of pregnancy
- Hyperemesis gravidarum (2nd line)
Mechanism
D2 antagonism in CTZ; also H1 and muscarinic blockade contributing to antiemetic effect and side-effect profile.
"Stemetil = stem the vomit"
- Buccal absorbs when you can't swallow
- Watch for dystonia in young women
- Avoid QT-prolonging combos
Dosing
- PO
- 5–10 mg TDS
- Buccal
- 3–6 mg BD (between gum and upper lip)
- IM
- 12.5 mg, repeat 6-hourly PRN
Contraindications
- AbsoluteParkinson's disease
- AbsoluteProlonged QT / concurrent QT drugs
- CautionElderly (stroke risk with antipsychotics)
Side effects
- Extrapyramidal reactions (esp. young women)
- Sedation
- Postural hypotension
- QT prolongation
- Cholestatic jaundice (rare)
Fetal & maternal notes
- • No consistent teratogenic signal
- • Neonatal extrapyramidal / withdrawal symptoms if used near term
Key interactions
Ondansetron
CautionAdditive QT prolongation
Levodopa
AvoidAntagonised
Alcohol / CNS depressants
CautionSedation
Clinical pearls
- 💡 Buccastem 3 mg absorbed transbuccally — useful when vomiting
- 💡 Reserve for cyclizine failures
Content last reviewed: REPLACE_ME (e.g. 2026-07)
Spotted something out of date? See our disclaimer or use Report an Error above.